a 2023

Analysis of factors influencing the decision to stop TKI treatment in CML patients in deep molecular response

SEMERÁD, Lukáš, Daniela ŽÁČKOVÁ, Petra BĚLOHLÁVKOVÁ, Jaroslava VOGLOVÁ, Pavel ŽÁK et. al.

Basic information

Original name

Analysis of factors influencing the decision to stop TKI treatment in CML patients in deep molecular response

Authors

SEMERÁD, Lukáš (203 Czech Republic, belonging to the institution), Daniela ŽÁČKOVÁ (203 Czech Republic, belonging to the institution), Petra BĚLOHLÁVKOVÁ (203 Czech Republic, belonging to the institution), Jaroslava VOGLOVÁ (203 Czech Republic, belonging to the institution), Pavel ŽÁK (203 Czech Republic, belonging to the institution), Edgar FABER (703 Slovakia, belonging to the institution), Tomáš PAPAJÍK (203 Czech Republic, belonging to the institution), I. SKOUMALOVÁ (203 Czech Republic), M. KARAS, P. JINDRA, H. KLAMOVÁ, C. ŠÁLEK, D. SRBOVÁ, H. ŽIŽKOVÁ, L. STEJSKAL, Olga ČERNÁ (203 Czech Republic), Eduard CMUNT (203 Czech Republic, belonging to the institution), Petra ČIČÁTKOVÁ (203 Czech Republic, belonging to the institution), Anežka KVETKOVÁ (703 Slovakia, belonging to the institution), Tomáš HORŇÁK (703 Slovakia, belonging to the institution), Ivana JEŽÍŠKOVÁ (203 Czech Republic, belonging to the institution), Tomáš JURČEK (203 Czech Republic, belonging to the institution), Barbora WEINBERGEROVÁ (203 Czech Republic, belonging to the institution), Jiřina PROCHÁZKOVÁ (203 Czech Republic, belonging to the institution), Kateřina MACHOVÁ POLÁKOVÁ (203 Czech Republic, belonging to the institution), Adam SVOBODNÍK (203 Czech Republic, belonging to the institution), Radka ŠTĚPÁNOVÁ (203 Czech Republic, belonging to the institution) and Jiří MAYER (203 Czech Republic, belonging to the institution)

Edition

XXXV. Olomoucké hematologické dny in Transfuze a Hematologie Dnes, 2023

Other information

Language

English

Type of outcome

Konferenční abstrakt

Field of Study

30205 Hematology

Country of publisher

Czech Republic

Confidentiality degree

není předmětem státního či obchodního tajemství

RIV identification code

RIV/00216224:14110/23:00131076

Organization unit

Faculty of Medicine

Keywords in English

CML; TKI treatment; deep molecular response

Tags

rivok
Změněno: 6/8/2024 10:23, Mgr. Tereza Miškechová

Abstract

V originále

Analysis of factors influencing the decision to stop TKI treatment in CML patients in deep molecular response - conference abstract.

Links

LX22NPO5102, research and development project
Name: Národní ústav pro výzkum rakoviny (Acronym: NÚVR)
Investor: Ministry of Education, Youth and Sports of the CR, National institute for cancer research, 5.1 EXCELES
90249, large research infrastructures
Name: CZECRIN IV
Displayed: 2/11/2024 05:12